To date, a few markers such as hepatoma-specific γ-glutamyl transferase, hepatoma-specific AFP, oncofetal antigen glypican-3, and member 3a of Wingless-type MMTV integration site family have been developed as specific biomarkers for HCC [11–13]. The gene discussed is AFP; the disease is hepatocellular carcinoma.